Authors

Verena Bertram

Salary Partner

Read More

Dr Paul England, DPhil Oxon

Senior Professional Support Lawyer

Read More

Agnieszka Sztoldman

Senior Associate

Read More
Authors

Verena Bertram

Salary Partner

Read More

Dr Paul England, DPhil Oxon

Senior Professional Support Lawyer

Read More

Agnieszka Sztoldman

Senior Associate

Read More

26 November 2019

Synapse - November 2019

This month on Synapse

SPC manufacturing waiver (Part 1): You may now – yes, what actually?

Verena Bertram and Anja Lunze address which activities the manufacturing waiver regulation actually privileges.

Poland changes course on its Bolar provision

Agnieszka Sztoldman explains how Poland is about to adopt a more lenient approach to the Bolar provision.

A Formstein objection in the UK?

Paul England looks at how the UK courts might apply the doctrine of equivalents to patent claims in the context of determining novelty or other validity objections.

A way into the UPC for post-Brexit Britain?

Paul England explores what the EU Parliament's recent analysis tells us about the likelihood of UK participation in the UPC.

Patents diary: November 2019

In this month's update, Josie Miller looks at the UK Supreme Court decision in the long-running Shanks v Unilever case about inventor compensation.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Life sciences & healthcare

Synapse - January 2020

16 January 2020

by multiple authors

Click here to find out more
Life sciences & healthcare

Synapse - December 2019

19 December 2019

by multiple authors

Click here to find out more
Patterned pills on green background
Patents & innovation

SPC manufacturing waiver (Part 1): You may now – yes, what actually?

29 November 2019

by Verena Bertram and Dr. Anja Lunze, LL.M.

Click here to find out more